The dinuclear radical anion complexes [(mu-L)[Re(CO)(3)Cl](2)](*)(-), L = 2,2'-azobispyridine (abpy) and 2,2'-azobis(5-chloropyrimidine) (abcp), were investigated by EPR at 9.5, 94, 230, and 285 GHz (abpy complex) and at 9.5 and 285 GHz (abcp complex). Whereas the X-band measurements yielded only the isotropic metal hyperfine coupling of the (185,187)Re isotopes, the high-frequency EPR experiments in glassy frozen CH(2)Cl(2)/toluene solution revealed the g components. Both the a((185,187)Re) value and the g anisotropy, g(1) - g(3), are larger for the abcp complex, which contains the better pi-accepting bridging ligand. Confirmation for this comes also from IR and UV/vis spectroscopy of the new [(mu-abcp)[Re(CO)(3)Cl](2)](o/)(*)(-)(/2)(-) redox system. The g values are reproduced reasonably well by density functional calculations which confirm higher metal participation at the singly occupied MO and therefore larger contributions from the metal atoms to the g anisotropy in abcp systems compared to abpy complexes. Additional calculations for a series of systems [(mu-abcp)[M(CO)(3)X](2)](*)(-) (M = Tc or Re and X = Cl, and X = F, Cl, or Br with M = Re) provided further insight into the relationship between spin density distribution and g anisotropy.
The molecular rectangle [(bp)2(bpym)2(OC)12Re4]4+ (bp = 4,4‘-bipyridine and bpym = 2,2‘-bipyrimidine) undergoes several reversible reduction processes in DMF solution. UV/vis and IR spectroelectrochemistry shows that the two bpym ligands are reduced twice by one electron each before the bp components pick up additional electrons in one-electron steps at more negative potentials.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.